companydata.dkNOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2025
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331. The solvency ratio was 99.5%.
- Gross Profit
- 0 kr.
- Profit/Loss
- 119,380,365 kr.
- Equity
- 1,018,536,331 kr.
- Total Assets
- 1,023,487,276 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 119.4 mio. | 1 mia. | - |
| 2024 | - | -1 | 394.6 mio. | 1.3 mia. | - |
| 2023 | - | 1 | 261 mio. | 1 mia. | - |
| 2022 | - | -1 | 132.7 mio. | 903.5 mio. | 0 |
| 2021 | - | -33 t. | 56.1 mio. | 828.8 mio. | 0 |
Find more companies like NOVOZYMES BIOINDUSTRIAL CHINA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2024. Gross profit came to DKK -1, and the net result was DKK 394,633,084.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.